Wednesday, July 29, 2015

EyewireTV - Allergan Sells Generics Unit; Argus II for Dry AMD

In this week's EyewireTV, Teva, the world's largest generic drug company, agrees to acquire Allergan's generics unit for $40.5 billion in cash and stock; and Second Sight Medical Products announces the first implant and activation of the Argus II Retinal Prosthesis System in a dry AMD patient. Also, Opternative, a venture-backed startup, launches an online eye exam service that can provide a physician-issued prescription for glasses or contacts (940 Views)

Watch Video

Wednesday, July 22, 2015

EyewireTV — LASIK System Launched in US; Best Ophthalmology Hospitals

In this week's EyewireTV, Abbott announces the FDA approval and launch of the iDesign Advanced WaveScan Studio System for personalized LASIK treatment; and Oertli obtains CE mark for its OS4 surgical platform for vitreoretinal, cataract, and glaucoma surgery. Also, US News & World Report releases its annual "Best Hospitals" list and for the 12th consecutive year, Bascom Palmer Eye Institute was ranked the top hospital in ophthalmology. (1653 Views)

Watch Video

Monday, July 13, 2015

EyewireTV — Will MIGS Transform Glaucoma?

In this week's special edition of EyewireTV, early adopters of microinvasive glaucoma surgery discuss how MIGS may transform the future of glaucoma treatment and management. (2518 Views)

Watch Video

Wednesday, July 08, 2015

EyewireTV — Allergan Acquires Dry Eye Candidate, Smart Watch App for Visually Impaired

In this week’s EyewireTV, Allergan agrees to acquire medical device maker Oculeve, developer of a non-invasive nasal neurostimulation device that increases tear production in dry eye patients; and Biogen enters into a major collaboration and licensing agreement with Applied Genetic Technologies Corporation (AGTC) to develop gene-based therapies for multiple ophthalmic diseases. Also, Novartis launches the first app for visually impaired people for use with smart watches. (1938 Views)

Watch Video

Wednesday, July 01, 2015

EyewireTV — Glaukos IPO, New Blindness Navigation Device, IOL Growth

In this week's EyewireTV, Glaukos, maker of the iStent Trabecular Micro-Bypass, is now available for public trade on the New York Stock Exchange; and the FDA approves a device that can help orient people who are blind by helping them process visual images with their tongues. Also, a Market Scope report shows steady growth in the global IOL market over the next 5 years and a number of enhancements to IOL designs. (2460 Views)

Watch Video

Wednesday, June 24, 2015

EyewireTV — Ophthalmic Innovator Robert Sinskey, MD, is Remembered; Long-Term Argus II Results

In this week's EyewireTV, world-renowned cataract surgeon, inventor, and pioneer Robert Sinskey, MD, passes away; and long-term results of a clinical trial examining the Argus II Retinal Prosthesis System are released for the first time. Also, Imprimis Pharmaceuticals acquires the rights to novel proprietary sedation and anesthesia formulations that are administered under the tongue during ocular and other surgical procedures. (2526 Views)

Watch Video

Wednesday, June 17, 2015

EyewireTV — Live Coverage of OC Ophthalmology Technology Summit, New Rhopressa Trial

In this week's EyewireTV, the FDA allows Aerie Pharmaceuticals to change the primary endpoint range of its second phase 3 registration trial of glaucoma candidate Rhopressa; and Lensar receives CE Mark approval in Europe for its Streamline application upgrades. In the feature, some of the industry’s top business leaders at the Orange County Ophthalmology Technology Summit in Costa Mesa, California, share their thoughts on what they believe are the best investment opportunities in ophthalmology. (2607 Views)

Watch Video

Wednesday, June 10, 2015

EyewireTV — QLT Buys InSite, Zeiss Developing OCT Angiography

In this week's EyewireTV, Canadian biotechnology company QLT signs a definitive agreement to buy InSite Vision in an all-stock deal; and Carl Zeiss Meditec announces it is developing OCT angiography for spectral-domain and swept-source platforms. Also, new research shows that people who wear contact lenses have different microorganisms living on the surface of their eyes than those who do not, possibly explaining why they tend to have more eye infections. (3144 Views)

Watch Video

Wednesday, June 03, 2015

EyewireTV — Glaucoma Pharma Study, Severe Vision Loss-Poverty Link

In this week’s EyewireTV, a Market Scope report reveals that, after years of decline, the global glaucoma pharmaceutical market is expected to climb significantly over the next 5 years due to robust growth in the emerging markets; and a study by the Centers for Disease Control and Prevention shows that there is a significant correlation between severe vision loss and counties located in the southern United States that have high poverty levels. Also, microscope maker Leica Microsystems signs a definitive agreement to acquire Bioptigen, a provider of OCT technology. (3163 Views)

Watch Video

Wednesday, May 27, 2015

EyewireTV — Omidria Recommendation, Pediatric Visual Impairment Study

In this week’s EyewireTV, a month after the commercial launch of Omidria (phenylephrine and ketorolac injection 1%/0.3%) in the United States, European drug regulators have recommended the agent for use during lens replacement surgery; and a large British study of children aged 7 to 9 finds that visual impairment is rarely the cause of pediatric reading problems. Also, Nidek launches the GYC-500 Vixi Green Scan/GYC-500 Green Laser photocoagulator. (3329 Views)

Watch Video

Wednesday, May 20, 2015

Phase 3 Dry Eye Drug Candidate Results, Fovista Update

In this week's EyewireTV, Eleven Biotherapeutics announces that its lead dry eye drug candidate (EBI-005) did not meet either of the two coprimary endpoints in a phase 3 study; and Ocular Therapeutix plans to submit a new drug application to the FDA for its postsurgical ocular pain drug candidate OTX-DP (Dextenza). Also, Ophthotech provides an update and timing projections on its Fovista phase 3 program, which consists of three clinical trials to evaluate the safety and efficacy of Fovista for the treatment of wet AMD. (2505 Views)

Watch Video

Wednesday, May 13, 2015

EyewireTV — Ebola Virus in Eye, AMO iDesign Clearance

In this week's EyewireTV, a report published online in the New England Journal of Medicine reveals that the Ebola virus remained live in the aqueous humor of an Ebola survivor for more than 2 months after recovery; and Abbott Medical Optics receives FDA clearance for the iDesign Advanced Wavescan Studio system for use in LASIK procedures. Also, Regeneron reports that sales of its blockbuster drug Eylea (aflibercept) increased 51% in the United States to $541 million in the first quarter of 2015. (2992 Views)

Watch Video
Load More